Hims & Hers Reports Strong Q2 2026 Growth on International Expansion
Event summary
- Hims & Hers reported a 38% year-over-year revenue increase to $753.2 million in Q2 2026.
- International revenue surged over 1,641%, driven by the Eucalyptus acquisition.
- Subscribers grew 19% year-over-year to 2.89 million.
- Adjusted EBITDA declined to $60.3 million from $82.2 million in Q2 2025.
- The company raised its 2026 revenue outlook to $3.1 billion–$3.3 billion.
The big picture
Hims & Hers is doubling down on international expansion, a strategic pivot that contrasts with peers focusing on domestic consolidation. The Eucalyptus acquisition marks a bold bet on scaling outside the U.S., but profitability concerns linger as adjusted EBITDA margins contract. The company's AI-driven clinical engine could be a differentiator if execution aligns with revenue targets.
What we're watching
- International Scaling
- The pace at which Hims & Hers can sustain its international growth trajectory post-Eucalyptus acquisition.
- Profitability Pressures
- Whether the company can improve its adjusted EBITDA margin amid aggressive expansion efforts.
- AI Integration
- How the AI clinical engine will impact operational efficiency and customer retention.
Related topics